Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
6.62
-0.37 (-5.29%)
Mar 31, 2025, 1:41 PM EDT - Market open

Immunome Statistics

Total Valuation

Immunome has a market cap or net worth of $575.61 million. The enterprise value is $359.66 million.

Market Cap 575.61M
Enterprise Value 359.66M

Important Dates

The last earnings date was Wednesday, March 19, 2025, after market close.

Earnings Date Mar 19, 2025
Ex-Dividend Date n/a

Share Statistics

Immunome has 86.95 million shares outstanding. The number of shares has increased by 195.51% in one year.

Current Share Class 86.95M
Shares Outstanding 86.95M
Shares Change (YoY) +195.51%
Shares Change (QoQ) +4.37%
Owned by Insiders (%) 3.35%
Owned by Institutions (%) 55.31%
Float 69.55M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 45.34
Forward PS n/a
PB Ratio 2.49
P/TBV Ratio 3.16
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 39.78
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.03.

Current Ratio 4.08
Quick Ratio 4.00
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -194.63% and return on invested capital (ROIC) is -62.37%.

Return on Equity (ROE) -194.63%
Return on Assets (ROA) -49.34%
Return on Invested Capital (ROIC) -62.37%
Return on Capital Employed (ROCE) -82.53%
Revenue Per Employee $76,619
Profits Per Employee -$2.48M
Employee Count 118
Asset Turnover 0.05
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -73.34% in the last 52 weeks. The beta is 1.94, so Immunome's price volatility has been higher than the market average.

Beta (5Y) 1.94
52-Week Price Change -73.34%
50-Day Moving Average 9.42
200-Day Moving Average 12.08
Relative Strength Index (RSI) 28.65
Average Volume (20 Days) 1,013,495

Short Selling Information

The latest short interest is 9.52 million, so 10.95% of the outstanding shares have been sold short.

Short Interest 9.52M
Short Previous Month 9.30M
Short % of Shares Out 10.95%
Short % of Float 13.69%
Short Ratio (days to cover) 13.83

Income Statement

In the last 12 months, Immunome had revenue of $9.04 million and -$292.96 million in losses. Loss per share was -$5.00.

Revenue 9.04M
Gross Profit -120.50M
Operating Income -153.46M
Pretax Income -232.03M
Net Income -292.96M
EBITDA -151.89M
EBIT -153.46M
Loss Per Share -$5.00
Full Income Statement

Balance Sheet

The company has $217.30 million in cash and $4.83 million in debt, giving a net cash position of $212.47 million or $2.44 per share.

Cash & Cash Equivalents 217.30M
Total Debt 4.83M
Net Cash 212.47M
Net Cash Per Share $2.44
Equity (Book Value) 181.17M
Book Value Per Share 2.81
Working Capital 167.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$110.79 million and capital expenditures -$53.51 million, giving a free cash flow of -$164.30 million.

Operating Cash Flow -110.79M
Capital Expenditures -53.51M
Free Cash Flow -164.30M
FCF Per Share -$1.89
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,697.33%
Pretax Margin -3,240.38%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Immunome does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -195.51%
Shareholder Yield -195.51%
Earnings Yield -51.21%
FCF Yield -28.72%

Analyst Forecast

The average price target for Immunome is $26.60, which is 301.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target $26.60
Price Target Difference 301.81%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 103.40%
EPS Growth Forecast (5Y) -27.90%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Immunome has an Altman Z-Score of 4.82 and a Piotroski F-Score of 1.

Altman Z-Score 4.82
Piotroski F-Score 1